Baktolak

General characteristics. Structure:

Structure: the lyophilized culture of living cells of lactobacilli of Lactobacillus acidophilus of piece 95/25. 1 bottle contains 5 doses. Dry powder contains not less than 108 living cells of lactobacilli in one dose.

Pharmacological properties:

Pharmacodynamics. Бактолакт treats group of eubiotik - the biogenic drugs representing the lyophilized mass of the live microorganisms which are usually living in intestines of the person. They are appointed at intestinal dysfunctions for prevention and treatment of dysbacteriosis which results from preferential reproduction of pathogenic microflora against the background of oppression of immunity and weakening of nonspecific factors of protection of a macroorganism.

Prolonged use of the antibiotics of a broad spectrum of activity suppressing development of normal intestinal microflora and glucocorticosteroids, and also influence of the ionizing radiation, breaking immunobiological reactivity of an organism is the most frequent reason of dysbacteriosis. The essence of purpose of eubiotik at dysbacteriosis consists that at hit in intestines the lyophilized bacteria come to life, quickly breed and create in it a normal biocenosis by competitive suppression of growth of pathogenic microflora.

Medicine бактолакт has high antagonistic activity in relation to pathogenic and conditionally pathogenic intestinal microflora (staphylococcus, to pseudo-monads, klebsiyella, salmonellas, shigellas, a protea, to enteropathogenic colibacilli) and recovers the broken digestive tract biocenosis. It is shown that it also has ability to activate products of interferon and to normalize nonspecific resistance of an organism.

Indications to use:

Бактолакт it is shown for use for adults and children, including newborn and premature. It is used for treatment of patients with dysbacteriosis, at chronic enterita and colitis, and also at the patients who had acute intestinal infections. Бактолакт apply also at treatment of patients with long intestinal dysfunctions of an unspecified etiology.

For prevention of dysbacteriosis drug appoint later long antibiotiko-, himio-and radiation therapy.

Unlike many eubiotik бактолакт it is possible to apply at patients against the background of the continuing antibioticotherapia.

Drug is effective as prophylactic at early transfer of children of chest age into artificial feeding or feeding by donor milk.

Route of administration and doses:

Бактолакт it is intended for internal use. Before use bottles open and dissolve their contents boiled water of room temperature at the rate of 1 tablespoon of water on one bottle. Drug is dissolved within 5 minutes with formation of a homogeneous suspension of cream color with a sour-milk smell. Then contents are transferred to glass with water (milk), mixed and drunk.

Бактолакт it is necessary to apply in 30 minutes prior to food or between meals and it is desirable to wash down with milk.

Adults are recommended to accept till 5-10 drug doses 3 times a day. At appointment a day less than 15 doses of a baktolakt efficiency of treatment considerably decreases.

To newborn children appoint 1-2 doses of a baktolakt to reception 3 times a day.

To children of the first half of the year of life drug is appointed on 3 doses to reception by 3 times a day.

To children of the second half of the year of life – on 5 doses on reception 3 times a day.

To children is more senior than one year - till 5-10 doses on reception 3 times a day.

Duration of a course of treatment drug - from 10 days to 1,5 months.

Side effects:

At use of a baktolakt side reactions are not revealed.

Interaction with other medicines:

Бактолакт it is possible to apply together with other medicines.

At treatment baktolakty it is necessary to avoid the use of the foodstuff having phytoncidal activity (garlic, onions). The used strain producer 95/25 резистентен to influence of antimicrobic drugs (Oxacillinum, chloramphenicol); слабочувствителен to a tseklor, norfloxacin, polymyxin.

Contraindications:

Contraindications to use of a baktolakt are not established.

Overdose:

About cases of overdose of drug it was not reported.

Issue conditions:

Without recipe

Packaging:

The powder lyophilized for preparation of suspension for intake in bottles of 5 doses in packaging No. 6, No. 40.